Related Experiment Video
Updated: Jul 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The screening of the second-site suppressor mutations of the common p53 mutants
Kazunori Otsuka1, Shunsuke Kato, Yuichi Kakudo
1Department of Clinical Oncology, Institute of Development, Aging and Cancer, and Tohoku University Hospital, Tohoku University, Sendai, Japan.
Abstract:
Second-site suppressor (SSS) mutations in p53 found by random mutagenesis have shown to restore the inactivated function of some tumor-derived p53. To screen novel SSS mutations against common mutant p53s, intragenic second-site (SS) mutations were introduced into mutant p53 cDNA in a comprehensive manner by using a p53 missense mutation library. The resulting mutant p53s with background and SS mutations were assayed for their ability to restore the p53 transactivation function in both yeast and human cell systems. We identified 12 novel SSS mutations including H178Y against a common mutation G245S. Surprisingly, the G245S phenotype is rescued when coexpressed with p53 bearing the H178Y mutation. This result indicated that there is a possibility that intragenic suppressor mutations might restore the protein function in an intermolecular manner. The intermolecular mechanism may lead to novel strategies for restoring inactivated p53 function and tumor suppression in cancer treatment.
Insights
Second-site suppressor mutations can restore tumor suppressor p53 function. Novel mutations, like H178Y, rescued common p53 mutations, suggesting intermolecular mechanisms for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Tumor suppressor protein p53 is frequently inactivated in cancers.
- Second-site suppressor (SSS) mutations can restore the function of mutant p53.
- Identifying novel SSS mutations is crucial for therapeutic strategies.
Purpose of the Study:
- To screen for novel intragenic second-site (SS) mutations that restore the transactivation function of common tumor-derived p53 mutants.
- To investigate potential intermolecular mechanisms of SSS mutations.
Main Methods:
- Utilized a p53 missense mutation library to introduce intragenic SS mutations.
- Assayed transactivation function restoration in yeast and human cell systems.
- Identified and characterized novel SSS mutations, including H178Y against G245S.
Main Results:
- Identified 12 novel SSS mutations capable of restoring p53 transactivation.
- The H178Y mutation was found to rescue the G245S p53 mutant phenotype.
- Demonstrated that intragenic suppressor mutations may restore protein function intermolecularly.
Conclusions:
- Novel SSS mutations can effectively restore the function of mutant p53.
- The discovery of intermolecular mechanisms opens new avenues for cancer therapy.
- These findings may lead to novel strategies for reactivating p53 and enhancing tumor suppression.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

